Vincent W. Wong
Data, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 114 publications
Correction: The Asian Pacific Association of the Study of the Liver expert survey on artificial intelligence-assisted reporting of liver histopathology in metabolic dysfunction associated fatty liver disease.
Journal: Hepatology international
Published: August 24, 2026
The Natural History and Individualized Prediction of Liver Stiffness-Based Fibrosis Risk in MASLD.
Journal: Clinical and molecular hepatology
Published: March 04, 2026
The natural history and individualized prediction of liver stiffness-based fibrosis risk in metabolic dysfunction-associated steatotic liver disease.
Journal: Clinical and molecular hepatology
Published: March 04, 2026
Real world tirzepatide treatment for fatty liver disease.
Journal: Hepatology international
Published: January 07, 2026
The Asian Pacific Association of the Study of the Liver expert survey on artificial intelligence-assisted reporting of liver histopathology in metabolic dysfunction associated fatty liver disease.
Journal: Hepatology international
Published: November 18, 2025
The Asian Pacific Association of the Study of the Liver expert survey on artificial intelligence-assisted reporting of liver histopathology in metabolic dysfunction associated fatty liver disease.
Journal: Hepatology international
Published: November 18, 2025
Higher Incidence of Hepatocellular Carcinoma in Suppressed Hepatitis B Cirrhosis Compared With Cured Hepatitis C Cirrhosis.
Journal: The American journal of gastroenterology
Published: October 13, 2025
Risk of Complicated Upper Gastrointestinal Bleeding With Direct Oral Anticoagulants: An Asian Population-Based Analysis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 03, 2025
Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease.
Journal: Gut
Published: February 04, 2025
Author Correction: Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut-liver axis.
Journal: Nature metabolism
Published: January 21, 2025
Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis.
Journal: Nature medicine
Published: October 08, 2024
Last Updated: 09/26/2026